Pharma Co. Oversold Dialysis Drug Potential, Suit Claims
Biopharmaceutical company Rockwell Medical Inc. misled investors into believing its dialysis drug, Triferic, was poised to dominate the market, causing share prices to fall when regulatory complications were revealed, a proposed...To view the full article, register now.
Already a subscriber? Click here to view full article